Andreas Kogelnik: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) |
Notjusttired (talk | contribs) m (Text replacement - " \| ?last(.*)\=(.*)( *)\| ?first(.*)\=(.*)( *)\| ?author" to " |last$1=$2 |first$3$4 |author") |
||
Line 60: | Line 60: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Montoya, 2013">{{Citation | <ref name="Montoya, 2013">{{Citation |last1 = Montoya |first 1 |authorlink1 = Jose Montoya |last2 = Kogelnik |first 2 |authorlink2 = Andreas Kogelnik |last3 = Bhangoo |first 3 |authorlink3 = |last4 = Lunn |first 4 |authorlink4 = |last5 = Flamand |first 5 |authorlink5 = |last6 = Merrihew |first 6 |authorlink6 = |last7 = Watt |first 7 |authorlink7 = |last8 = Kubo |first 8 |authorlink8 = |last9 = Paik |first 9 |authorlink9 = |last10 = Desai |first 10 |authorlink10 = | ||
| last1 = Montoya | |||
| last2 = Kogelnik | |||
| last3 = Bhangoo | |||
| last4 = Lunn | |||
| last5 = Flamand | |||
| last6 = Merrihew | |||
| last7 = Watt | |||
| last8 = Kubo | |||
| last9 = Paik | |||
| last10 = Desai | |||
| title = Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. | | title = Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. | ||
| journal = Journal of Medical Virology | volume = 85 | issue = 12 | page = 2101-9 | | journal = Journal of Medical Virology | volume = 85 | issue = 12 | page = 2101-9 | ||
Line 78: | Line 68: | ||
}} | }} | ||
</ref> | </ref> | ||
<ref name="Unger, 2017">{{Citation | <ref name="Unger, 2017">{{Citation |last1 = Unger |first 1 |authorlink1 = Elizabeth Unger |last2 = Lin |first 2 |authorlink2 = Jin-Mann Sally Lin |last3 = Tian |first 3 |authorlink3 = |last4 = Natelson |first 4 |authorlink4 = Benjamin Natelson |last5 = Lange |first 5 |authorlink5 = Gudrun Lange |last6 = Vu |first 6 |authorlink6 = |last7 = Blate |first 7 |authorlink7 = |last8 = Klimas |first 8 |authorlink8 = Nancy Klimas |last9 = Balbin |first 9 |authorlink9 = Elizabeth Balbin |last10 = Bateman |first 10 |authorlink10 = Lucinda Bateman |last11 = Allen |first 11 |authorlink11 = |last12 = Lapp |first 12 |authorlink12 = Charles Lapp |last13 = Springs |first 13 |authorlink13 = |last14 = Kogelnik |first 14 |authorlink14 = Andreas Kogelnik |last15 = Phan |first 15 |authorlink15 = |last16 = Danver |first 16 |authorlink16 = |last17 = Podell |first 17 |authorlink17 = Richard Podell | ||
| last1 = Unger | | last18 = Fitzpatrick | first18 = Trisha | authorlink18 = |last19 = Peterson |first 19 |authorlink19 = Daniel Peterson | ||
| last2 = Lin | |||
| last3 = Tian | |||
| last4 = Natelson | |||
| last5 = Lange | |||
| last6 = Vu | |||
| last7 = Blate | |||
| last8 = Klimas | |||
| last9 = Balbin | |||
| last10 = Bateman | |||
| last11 = Allen | |||
| last12 = Lapp | |||
| last13 = Springs | |||
| last14 = Kogelnik | |||
| last15 = Phan | |||
| last16 = Danver | |||
| last17 = Podell | |||
| last18 = Fitzpatrick | first18 = Trisha | authorlink18 = | |||
| last19 = Peterson | |||
| last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | | last20 = Gottschalk | first20 = C. Gunnar | authorlink20 = Gunnar Gottschalk | ||
| last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan | | last21 = Rajeevan | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan |
Revision as of 06:05, May 11, 2022
Andreas ("Andy") M. Kogelnik, MD, PhD, is an internal medicine and infectious diseases specialist and the director of the Open Medicine Institute, Mountain View, California, US.[1] His interests are in bioinformatics and genomic medicine and is committed to the study and treatment of ME/CFS and other chronic illnesses.[1]
Education[edit | edit source]
- MD from Emory University[1]
- PhD in bioengineering from Georgia Tech[1]
- Residency in internal medicine at Stanford University[1]
- Fellowship in infectious diseases at Stanford University[1]
ME/CFS Common Data Element (CDE) Project[edit | edit source]
Kogelnik is a member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project, sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[2]
Research publications on ME/CFS[edit | edit source]
- 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue[3] - (Abstract)
- 2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected[4] - (Full text)
- 2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir in a Subset of Patients With Chronic Fatigue Syndrome[5] - (Full text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[6] - (Full text)
Articles[edit | edit source]
Talks and interviews[edit | edit source]
- May 2011 - Keynote Speaker at the 6th Invest in ME International ME Conference - Speech Title: Strategies for ME Research and Collaboration[7]
- 2012, ME/CFS Alert Episode 23:
- The Open Medicine Institute, Part 1,
- The Open Medicine Institute, Part 2,
- The Open Medicine Institute, Part 3
- 2012, ME/CFS Alert Episode 22:
- 2012, 7th Invest in ME International ME Conference - Strategies for ME Research and Collaboration[8]
- 2013, 8th Invest in ME International ME Conference Keynote Speaker: Strategies for ME Research and Collaboration[9]
- 2014, YouTube - What Works For Chronic Fatigue Syndrome
- 2014, 9th Invest in ME International ME Conference 2014 - No title of talk given
- 2014, ME/CFS Alert Episode 56: Dr. Andreas Kogelnik on the "Real Thrust" of ME/CFS Research
- 2014, ME/CFS Alert Episode 55: Interview with Dr. Andreas Kogelnik
- 17 Feb 2014, Dr. Andreas Kogelnik and Llewellyn King on Sirius XM Radio POTUS Channel 124
- 23 Jan 2014, “The Jim Bohannon Show” with guests, Dr. Andreas Kogelnik, Ryan Prior and Llewellyn King
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "The Clinic". Open Medicine Institute. Retrieved April 17, 2019.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ Kogelnik, AM; Loomis, K; Hoegh-Petersen, M; Rosso, F; Hischier, C; Montoya, JG. "Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue". Journal of Clinical Virology. 37: Suppl 1:S33-8. doi:10.1016/S1386-6532(06)70009-9. PMID 17276366.
- ↑ Knox, K.; Carrigan, D.; Simmons, G.; Teque, F.; Zhou, Y.; Hackett, J.; Qiu, X.; Luk, K.-C.; Schochetman, G.; Kogelnik, AM (July 1, 2011). "No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected". Science. 333 (6038): 94–97. doi:10.1126/science.1204963. ISSN 0036-8075.
- ↑ 1first 2 first 1 first 3 first 2, "Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome."
- ↑ 1first 2 first 1 first 3 first 2, "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study."
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
- ↑ "Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.